Market Size of Asia-Pacific Mammography Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Market Size (2024) | USD 521.17 Million |
| Market Size (2029) | USD 834.41 Million |
| CAGR (2024 - 2029) | 9.87 % |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Asia-Pacific Mammography Market Analysis
The Asia-Pacific Mammography Market size is estimated at USD 521.17 million in 2024, and is expected to reach USD 834.41 million by 2029, growing at a CAGR of 9.87% during the forecast period (2024-2029).
The major factors contributing to the growth of the Asia-Pacific mammography market are the rising incidence of breast cancer, large R&D investment in breast cancer therapies, and advances in breast imaging modalities. In most Asian countries, breast cancer is the most common cancer. Incidence rates increase at a faster rate than in Western countries due to lifestyle and dietary changes. The Center for Disease Control (CDC) reports breast cancer to be one of the most common cancers among women, irrespective of race or ethnicity. The rising prevalence of breast cancer and the growing healthcare infrastructure in the region is expected to drive the overall growth. As per the GLOBOCAN 2018, the estimated age-standardized incidence rate of breast cancer in Asia is 34.4 per 100,00. The other factors helping the growth of the mammography market are the rapid increase in population.
Asia-Pacific Mammography Industry Segmentation
In basic terms, mammography refers to a standard diagnostic and screening technique used to screen breast tissues to check the presence of a malignant tumor. The process involves the usage of low-energy X-rays for early detection of breast cancer.
| By Product Type | |
| Digital Systems | |
| Analog Systems | |
| Breast Tomosynthesis | |
| Film Screen Systems | |
| Other Product Types |
| By End Users | |
| Hospitals | |
| Diagnostic Centers | |
| Others |
| Geography | ||||||||
|
Asia-Pacific Mammography Market Size Summary
The Asia-Pacific mammography market is poised for significant growth, driven by the increasing incidence of breast cancer and advancements in breast imaging technologies. The region faces a rising prevalence of breast cancer, which is becoming the most common cancer among women, influenced by lifestyle and dietary changes. This surge in incidence rates, coupled with substantial investments in research and development for breast cancer therapies, is propelling the demand for mammography services. The healthcare infrastructure in Asia-Pacific is also expanding, further supporting market growth. Digital mammography, with its advanced imaging capabilities and superior diagnostic quality, is gaining traction over conventional methods, despite its higher cost. This shift is expected to enhance the precision and efficiency of breast cancer screenings, contributing to the market's expansion during the forecast period.
The competitive landscape of the Asia-Pacific mammography market is characterized by the presence of several key players who are actively engaging in strategic initiatives such as acquisitions and joint ventures to strengthen their market positions. Major companies like Bayer AG, Pfizer Inc., Merck & Co., Inc., and others are leading the market, while also collaborating with firms like Fujifilm Holdings Corporation, GE Healthcare, and Siemens Healthineers AG to enhance their offerings. These strategic moves are aimed at consolidating market share and leveraging technological advancements to meet the growing demand for mammography services in the region. As digital mammography becomes the preferred choice due to its enhanced capabilities, the market is expected to witness robust growth, driven by both technological innovation and strategic market maneuvers.
Asia-Pacific Mammography Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Rising Incidences of Breast Cancer
-
1.2.2 Advancements in the Technologies of Breast Imaging Modalities
-
-
1.3 Market Restraints
-
1.3.1 High Cost of Imaging Devices
-
1.3.2 Risk of Adverse Effects of Radiation Exposure
-
-
1.4 Porter's Five Forces Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION
-
2.1 By Product Type
-
2.1.1 Digital Systems
-
2.1.2 Analog Systems
-
2.1.3 Breast Tomosynthesis
-
2.1.4 Film Screen Systems
-
2.1.5 Other Product Types
-
-
2.2 By End Users
-
2.2.1 Hospitals
-
2.2.2 Diagnostic Centers
-
2.2.3 Others
-
-
2.3 Geography
-
2.3.1 Asia-Pacific
-
2.3.1.1 China
-
2.3.1.2 Japan
-
2.3.1.3 India
-
2.3.1.4 Australia
-
2.3.1.5 South korea
-
2.3.1.6 Rest of Asia-Pacific
-
-
-
Asia-Pacific Mammography Market Size FAQs
How big is the Asia-Pacific Mammography Market?
The Asia-Pacific Mammography Market size is expected to reach USD 521.17 million in 2024 and grow at a CAGR of 9.87% to reach USD 834.41 million by 2029.
What is the current Asia-Pacific Mammography Market size?
In 2024, the Asia-Pacific Mammography Market size is expected to reach USD 521.17 million.
